Why Abzena?
Trust our focused approach.
Developing an efficient, scalable, validated, and cost-effective manufacturing process in the late development phase is essential for success in today’s competitive biologics and bioconjugates market.
Whether you need assistance developing a new process, are improving existing processes, or are preparing to manufacture your product, you will benefit from our in-depth expertise. Through a comprehensive technology transfer program, we deliver a successful scale-up model to ensure a robust and consistent manufacturing process from clinical through commercial scale.
We collaborate with your team to de-risk the pathway to commercialization, ensure manufacturability, and deliver a quality biologic medicine to the patient.
Designed to move medicine forward to commercial launch, Abzena are focused on two key enabling activities for those companies looking to bring biologics and bioconjugates to the market.
Our focus is on:
Abzena have the know-how and resources to meet your commercial needs. We collaborate with your team to de-risk the pathway to commercialization.
Through our technology transfer program and scale up model we can ensure a robust and consistent clinical to commercial manufacturing process. We ensure manufacturability, and will deliver a quality medicine to the patient.
The leading biologics CDMO + CRO that accelerates drug development, moving medicine forward for patients in need.